Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia.

Determinants of magnesium sulphate use in women hospitalized at <29 weeks with severe or non-severe pre-eclampsia.

Magnesium sulphate is recommended by international guidelines to prevent eclampsia among women with pre-eclampsia, especially when it is severe, but fewer than 70% of such women receive magnesium sulphate. We aimed to identify variables that prompt Canadian physicians to administer magnesium sulphat...

Full description

Bibliographic Details
Main Authors: Dane A De Silva, Lily Proctor, Peter von Dadelszen, Meghan McCoach, Tang Lee, Canadian Perinatal Network (CPN) Collaborative Group, Laura A Magee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5741231?pdf=render

Internet

http://europepmc.org/articles/PMC5741231?pdf=render

Similar Items